120 likes | 156 Views
Access full Research: <br><br>https://www.renub.com/auto-injectors-market-p.php<br><br><br>Global auto-injectors market is expected to be more than USD 5 Billion by 2024. According to Renub Research analysis auto-injectors market will grow at double digit CAGR from 2018-2024 due to auto-injectors self-administration features which ultimately reduces the patients drug delivery cost. Increasing prevalence of anaphylaxis, new formulations and new drug delivery systems, rising self-medication practices, government reimbursements and growing demand for targeted drug delivery systems for treatments of chronic diseases are some other driving forces for this market. However, regulatory hurdles for approval of new devices and Mylan’s EpiPen prices in United States are some of the key challenges for the auto-injectors market. From November 2004 to May 2016, EpiPen price has grown close to 500 percent in United States.<br>Auto-injector is a healthcare device used for fixed doses for the particular drug. It has two types of design prefilled and fillable. Auto-injectors design support user-friendly and are intended for self-administration by untrained people, by patients. In context of auto-injectors usability, it is available in re-usable and disposable form.<br>
E N D
Auto-injectors Market Analyst View: • Auto-injectors market is expected to be more than USD 5 Billion by 2024. Get Free Customization in this Report • Research Report Title: • Auto-injectors Market Global Forecast by Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types (Prefilled, Fillable), Usability (Reusable, Disposable), Distribution Channels (Online Pharmacies, Retail Pharmacies, Others) Regions (North America, Europe, Asia Pacific, Middle East & Africa), Companies (AntaresPharma, Mylan N.V, Amgen Inc, Novartis AG, Bayer AG) • Access Full Research: • https://www.renub.com/auto-injectors-market-p.php
Global auto-injectors market is expected to be more than USD 5 Billion by 2024 Global auto-injectors market is expected to be more than USD 5 Billion by 2024. According to Renub Research analysis auto-injectors market will grow at double digit CAGR from 2018-2024 due to auto-injectors self-administration features which ultimately reduces the patients drug delivery cost. Increasing prevalence of anaphylaxis, new formulations and new drug delivery systems, rising self-medication practices, government reimbursements and growing demand for targeted drug delivery systems for treatments of chronic diseases are some other driving forces for this market. However, regulatory hurdles for approval of new devices and Mylan’sEpiPen prices in United States are some of the key challenges for the auto-injectors market. From November 2004 to May 2016, EpiPen price has grown close to 500 percent in United States. Auto-injector is a healthcare device used for fixed doses for the particular drug. It has two types of design prefilled and fillable. Auto-injectors design support user-friendly and are intended for self-administration by untrained people, by patients. In context of auto-injectors usability, it is available in re-usable and disposable form. Request a free sample copy of the report: https://www.renub.com/contactus.php
Global auto-injectors market is expected to be more than USD 5 Billion by 2024 Renub Research report titled “Auto-injectors Market Global Forecast by Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types (Prefilled, Fillable), Usability (Reusable, Disposable), Distribution Channels (Online Pharmacies, Retail Pharmacies, Others) Regions (North America, Europe, Asia Pacific, Middle East & Africa), Companies (AntaresPharma, Mylan N.V, Amgen Inc, Novartis AG, Bayer AG)” studies the global auto-injectors market and provides an all-encompassing analysis of the key growth drivers and challenges, market trends, key players and their projections for the future. By Application - Market Segmentation Global auto-injectors market has been segmented by application such as Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others. Anaphylaxis is the leading application in global auto-injectors market. Multiple Sclerosis and Rheumatoid Arthritis are other two popular applications in this market place. By Product Design Types - Market Segmentation Global auto-injectors market has been studied by auto-injectors design types. Prefilled and Fillable is covered to define the global market by design types. According to our analysis, we found that Prefilled control majority share in this market place.
Global auto-injectors market is expected to be more than USD 5 Billion by 2024 By Product Usability - Market Segmentation This report has also been studied by product usability such as Reusable and Disposable. Disposable auto-injectors are driving this market place. By Distribution Channels - Market Segmentation In the global auto-injectors market place, online pharmacy channel is showing good growth for selling the auto-injectors. The other channel studied is Retail pharmacy. By Region - Market Segmentation Auto-injectors market by region has been segmented into North America, Europe, Asia Pacific, Middle East & Africa. North America is a leading market place due to increasing prevalence of anaphylaxis, favorable reimbursement policies and increase in healthcare expenditure. Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/auto-injectors-market-p.php
Global auto-injectors market is expected to be more than USD 5 Billion by 2024
Global auto-injectors market is expected to be more than USD 5 Billion by 2024 Key Players Some of the key players in the global auto-injectors market include AntaresPharma, Mylan N.V, Amgen Inc, Novartis AG, Bayer AG. The report has been analyzed from 8 major viewpoints 1. Applications 2. Design Types 3. Usability Types 4. Distribution Channels5. Regions 6. Companies7. Growth drivers 8. Challenges Segmentation based on Applications • Anaphylaxis • Multiple Sclerosis• Rheumatoid Arthritis • Others Segmentation based on Design Types • Prefilled • Fillable
Global auto-injectors market is expected to be more than USD 5 Billion by 2024 Segmentation based on Usability • Reusable • Disposable Segmentation based on World Regions • North America• Europe• Asia Pacific• Middle East & Africa Company Details • AntaresPharma• Mylan N.V• Amgen Inc• Novartis AG• Bayer AG.
Table of Contents Key Topics Covered 1. Executive Summary 2. Global Auto-Injectors Market 3. Market Share – Global Auto-Injectors 3.1 Geographical Regions 3.2 Application3.3 Product Type 3.4 Usability3.5 Distribution Channels 4. Regions – Auto-Injectors Market 4.1 North America 4.2 Asia Pacific4.3 Europe 4.4 GCC Countries and Africa 5. Application - Auto-Injectors Market 5.1 Anaphylaxis 5.2 Multiple Sclerosis5.3 Rheumatoid Arthritis 5.4 Others 6. Product Type - Auto-Injectors Market 6.1 Prefilled Auto-Injectors 6.2 Fillable Auto-Injectors
Table of Contents 7. Usability – Auto-Injectors Market 7.1 Reusable Auto-Injectors 7.2 Disposable Auto-Injectors 8. Distribution Channels – Auto-Injectors Market 8.1 Online Pharmacies 8.2 Retail Pharmacies8.3 Others 9. Growth Drivers 9.1 Increasing Prevalence of Food Allergy 9.2 Government Initiatives9.3 Decline in Price of Epipen 10. Challenges 10.1 Unmet Needs in Allergic Care 10.2 Regulatory Hurdle in United States 11. AntaresPharma, Inc – Company Analysis 11.1 Company Overview 11.2 Company Initiatives 11.3 Financial Insight
Table of Contents 12. Mylan N.V. – Company Analysis 12.1 Company Overview 12.2 Company Initiatives 12.3 Financial Insight 13. Amgen Inc. – Company Analysis 13.1 Company Overview 13.2 Company Initiatives 13.3 Financial Insight 14. Novartis AG – Company Analysis 14.1 Company Overview 14.2 Company Initiatives 14.3 Financial Insight 15. Bayer AG – Company Analysis 15.1 Company Overview 15.2 Company Initiatives 15.3 Financial Insight
GetFree Customization in this Report • Medical Devices Market Reports: • https://www.renub.com/medical-devices-15-c.php